Clarithromycin-hameln 500 mg - Pulver für ein Konzentrat zur Herstellung einer Infusionslösung New
Recall
|
Medicines
|
10/12/2025
The marketing authorisation holder informed its supplied customers on December 10, 2025, that the mentioned batches are being recalled as a precautionary measure due to deficiencies from the Good Manufacturing Practice at the active ingredient manufacturer.
| Name of the medicinal product | Clarithromycin-hameln 500 mg - Pulver für ein Konzentrat zur Herstellung einer Infusionslösung |
|---|---|
| Marketing authorisation number(s) | 1-38483 |
| CIP code | 4966053 |
| Marketing authorisation holder | hameln pharma gmbh |
| Batch number(s) | Charge, Verfalldatum 23L010, 30.09.2027 23L011, 30.11.2027 24E169, 30.04.2028 |
| Classification of the recall | 1 |
| Depth of recall | Pharmacies |
| BASG reference number | INS-640.001-5460 |
Further inquiry note
Page last modified:
10/12/2025